piribedil has been researched along with Clerambault Syndrome in 1 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Pronoran was prescribed in a dosage 50-100 mg/day during 3 months." | 1.32 | [Pronoran in the treatment of mental organic syndrome in the elderly]. ( Gavrilova, SI; Mikhaĭlova, NM; Sokolova, ON, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mikhaĭlova, NM | 1 |
| Sokolova, ON | 1 |
| Gavrilova, SI | 1 |
1 other study available for piribedil and Clerambault Syndrome
| Article | Year |
|---|---|
[Pronoran in the treatment of mental organic syndrome in the elderly].
Topics: Aged; Aged, 80 and over; Dopamine Agonists; Female; Humans; Male; Middle Aged; Neurocognitive Disord | 2004 |